NEW ISSUE
LM revascularisation, annulus rupture, risk stratification, renal denervation
May 20, 2020
1. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands, Netherlands
2. Department of Cardiology, Ospedale Manzoni, Lecco, Italy
3. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
4. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
5. Department of Cardiothoracic Surgery, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
6. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
7. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
8. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
2. Department of Cardiology, Ospedale Manzoni, Lecco, Italy
3. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
4. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
5. Department of Cardiothoracic Surgery, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
6. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
7. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
8. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.
Disclaimer:
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please log in to download the PDF.
Coronary artery fistulae (CAF) represent an abnormal communication bypassing the myocardial capillary bed between a coronary artery and either a cardiac chamber (coronary-cameral CAF) or a vascular structure from systemic or pulmonary circulation (coronary-vascular CAF). CAF represent a congenital anomaly in 0.2% of the population, but are more frequently found in heart transplant recipients (8%) mostly as coronary-right ventricle (RV) CAF caused by endomyocardial biopsy used for monitoring of rejection (1, 2). Other complications of myocardial biopsy include perforation of the RV wall and tricuspid valve damage (2). Several case-reports have shown successful transcatheter closure of CAF (3, 4). We Aims:ed to analyze the indications for transcatheter closure and the long-term prognosis of CAF in the heart transplant recipients.
Sign in to read and download the full article
Forgot your password?No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
stable anginacoronary fistulaother technique
Coronary interventionsOther coronary interventions